GWW vs SRPT · P/E 27, rev $9.76B vs rev $1.13B
WW Grainger Inc (GWW) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
WW Grainger Inc (GWW) is a industrial distribution company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported GWW revenue for 2026-06-30 was $9.76B. Net income was $1.13B. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
GWW currently screens at market cap $50.34B and trailing P/E 26.9. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the GWW and SRPT stock pages for the full models.
Not investment advice.